By Clinical Informatics News Staff

January 8, 2018 | Mayo Clinic and Veritas Genetics announced a collaboration today to make whole genome sequencing broadly available to healthy individuals.

As part of the collaboration, Mayo Clinic's Center for Individualized Medicine will provide medical and clinical expertise to the Veritas team, which will be integrated into Veritas’ myGenome product. Patients who qualify for a Mayo Clinic research study of healthy adults will be offered Veritas myGenome screening test for whole genome sequencing.

The collaboration will be led by Keith Stewart, M.B., Ch.B., medical director of Mayo's Center for Individualized Medicine, which will be funding the study. Any revenue that Mayo Clinic will receive as a result of this collaboration will be used to support its not-for-profit mission in patient care, education and research. Mayo Clinic will become a shareholder of Veritas.